Detectable ctDNA at the time of treatment cessation of ipilimumab and nivolumab for toxicity predicts disease progression in advanced melanoma patients by Lydia Warburton, Lydia Warburton, Anna Reid, Anna Reid, Benhur Amanuel, Benhur Amanuel, Leslie Calapre, Leslie Calapre, Michael Millward, Elin Gray, Elin Gray

Get full text

A scoping review of factors influencing the implementation of liquid biopsy for cancer care by Samran Sheriff, Maree Saba, Romika Patel, Georgia Fisher, Tanja Schroeder, Gaston Arnolda, Dan Luo, Lydia Warburton, Elin Gray, Georgina Long, Jeffrey Braithwaite, Helen Rizos, Louise Ann Ellis

Get full text

LOREALAUS: LOrlatinib REAL-World AUStralian Experience in Advanced ALK-Rearranged NSCLC by Marliese Alexander, B.Pharm(Hons), MPH, PhD, Joe Wei, MD, Sagun Parakh, MD, Thomas John, MD, Steven Kao, MD, Adnan Nagrial, MD, Samantha Bowyer, MD, Lydia Warburton, MD, Melissa Moore, MD, Brett G.M. Hughes, MD, Timothy D. Clay, MD, Nick Pavlakis, MD, Benjamin J. Solomon, MD, Malinda Itchins, MD

Get full text

First-line chemoimmunotherapy and immunotherapy in patients with non-small cell lung cancer and brain metastases: a registry study by Lauren Julia Brown, Lauren Julia Brown, Lauren Julia Brown, Lauren Julia Brown, Victor Khou, Victor Khou, Victor Khou, Chris Brown, Marliese Alexander, Marliese Alexander, Dasantha Jayamanne, Dasantha Jayamanne, Dasantha Jayamanne, Joe Wei, Lauren Gray, Wei Yen Chan, Wei Yen Chan, Samuel Smith, Susan Harden, Susan Harden, Antony Mersiades, Antony Mersiades, Lydia Warburton, Lydia Warburton, Malinda Itchins, Malinda Itchins, Malinda Itchins, Jenny H. Lee, Jenny H. Lee, Nick Pavlakis, Nick Pavlakis, Nick Pavlakis, Stephen J. Clarke, Stephen J. Clarke, Stephen J. Clarke, Michael Boyer, Michael Boyer, Adnan Nagrial, Adnan Nagrial, Adnan Nagrial, Eric Hau, Eric Hau, Eric Hau, Eric Hau, Ines Pires da Silva, Ines Pires da Silva, Ines Pires da Silva, Steven Kao, Steven Kao, Benjamin Y. Kong, Benjamin Y. Kong, Benjamin Y. Kong, Benjamin Y. Kong

Get full text